Literature DB >> 1455194

Free protein S deficiency in patients with chronic inflammatory bowel disease.

E Aadland1, O R Odegaard, A Røseth, K Try.   

Abstract

Free protein S, protein C, and C4b-binding protein (C4b-BP) were measured in randomly selected outpatients: 22 with Crohn's disease (CD) and 16 with ulcerative colitis (UC). Active disease was recorded in 10 patients with CD and 4 with UC. Fourteen patients (63.6%) with CD and 4 (25%) with UC had free protein S values below the normal range, with mean values of 62% and 78% of that found in healthy control subjects (p < 0.01). The C4b-BP level was 127% in patients with CD as compared with 89% in both healthy subjects and UC patients (p < 0.01). The protein C levels were similar in the three groups. The present results add to the factors already known favouring thromboembolic complications in inflammatory bowel disease and which might play a major role both for the pathogenesis and for the increased tendency to venous thromboembolism in these diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1455194     DOI: 10.3109/00365529209000170

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  17 in total

Review 1.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

2.  Increased levels of homocysteine in patients with ulcerative colitis.

Authors:  Sabiye Akbulut; Emin Altiparmak; Firdevs Topal; Ersan Ozaslan; Metin Kucukazman; Ozlem Yonem
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

Review 3.  Coagulopathies and inflammatory diseases: '…glimpse of a Snark'.

Authors:  Silvina Del Carmen; Sophie M Hapak; Sourav Ghosh; Carla V Rothlin
Journal:  Curr Opin Immunol       Date:  2018-09-27       Impact factor: 7.486

4.  Anti-cardiolipin antibodies in patients with inflammatory bowel disease.

Authors:  B W Aichbichler; W Petritsch; G A Reicht; H H Wenzl; A J Eherer; T A Hinterleitner; P Auer-Grumbach; G J Krejs
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

5.  Hyperhomocysteinemia in ulcerative colitis is related to folate levels.

Authors:  Petros Zezos; Georgia Papaioannou; Nikolaos Nikolaidis; Themistoclis Vasiliadis; Olga Giouleme; Nikolaos Evgenidis
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

6.  Budd-Chiari syndrome in a patient with ulcerative colitis and no inherited coagulopathy.

Authors:  Sunil Dacha; Manjari Devidi; Evan Osmundson
Journal:  World J Hepatol       Date:  2011-06-27

Review 7.  Thromboembolic complications in inflammatory bowel disease.

Authors:  Darina Kohoutova; Paula Moravkova; Peter Kruzliak; Jan Bures
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

Review 8.  Risk of cardiovascular disease in inflammatory bowel disease.

Authors:  Nynne Nyboe Andersen; Tine Jess
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

9.  Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease.

Authors:  I E Koutroubakis; E Petinaki; E Anagnostopoulou; H Kritikos; I A Mouzas; E A Kouroumalis; O N Manousos
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

10.  Assessment of thrombophilic abnormalities during the active state of inflammatory bowel disease.

Authors:  Maha M Maher; Somaya H Soloma
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.